Mitosure®
Mitochondrial Assessment
Menu
MitoSure® is a test performed on embryos that measures levels of mitochondrial DNA (mtDNA). Large amounts of mtDNA may be an indicator of developmental delay and implantation failure.
Recent studies have shown a link between high levels of mitochondrial DNA and poor implantation potential in embryos. Assessing mitochondrial content can offer additional information for your IVF team to select an embryo with a high likelihood of producing a successful pregnancy.
The MitoSure® test is performed simultaneously with Previda®. The test uses next-generation sequencing to measure the amount of mitochondrial DNA relative to nuclear DNA, which is translated into a MitoSure® Score.
At Progenesis, our patients are our highest priority.
We are happy to address any of your questions or concerns.
Progenesis Inc.
Address: 4150 Regents Park Row,
Suite 245,
La Jolla, CA 92037
Phone: (858) 257-2122
Fax: (888) 810-6079
Progenesis is a San Diego based company that develops and offers genetic testing services for patients throughout their family planning journey. Progenesis was the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic testing. Through optimization of the NGS platform, Progenesis confidently maintains the most accurate testing in the IVF field with the lowest rate of mosaicism.
